Engage for Late-Life Depression and Comorbid Executive Dysfunction

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-24

Study Completion Date

2025-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Although there are an increasing number of mental health treatment adaptations for older adults, there are still a number of factors to consider when making these adaptations. Cognitive decline is one such factor that places significant burden on older adults and can interfere with traditional mental health therapies. Engage is a behavioral treatment approach that has shown to be effective in treating late life depression. The investigators are testing the feasibility of Engage as a treatment method for late life depression in older adults with cognitive decline. The objective is to corroborate Engage as an alternative late life depression treatment method for a sub-population of older adults with cognitive decline. Cognitive decline poses a unique mental health treatment barrier that is often over looked in younger populations. With a relatively higher prevalence of cognitive decline in older adulthood, it is imperative that a feasible mental health treatment program that can be effective in the presence of cognitive decline.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparing Engage to PST for Late Life Depression

NCT02086201

Major Depression

COMPLETED NA

Psychotherapy for Late Life Depression

NCT01698255

Depression

COMPLETED NA

Targeting Burdensomeness Among Clinic Referred Youth

NCT03781037

Perceived Burdensomeness Toward Others

COMPLETED NA

Therapy for Depressed Elders With Thought Problems

NCT00052091

Depression Cognition Disorders

COMPLETED PHASE3

Metacognitive Training-Silver BeWell in Older Adults

NCT06312241

Depressive Symptoms Well-Being, Psychological

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression in Old Age Psychotherapy Mild Cognitive Impairment Executive Dysfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

The trial will be a single-arm feasibility trial of Engage for treatment of late-life depression in older adults with comorbid executive/cognitive dysfunction.

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Engage Treatment

The study is a single-arm study. The single-arm will be implementation of the 9-week protocol of Engage in an older adult population with late-life depression and comorbid executive dysfunction and mild cognitive impairment.

Group Type EXPERIMENTAL

Engage

Intervention Type BEHAVIORAL

Engage is a 9-week, behavioral-based, psychotherapy treatment protocol for late-life depression.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Engage

Engage is a 9-week, behavioral-based, psychotherapy treatment protocol for late-life depression.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 60 or older
* Ability to read, write, and speak English
* Located in Las Vegas or surrounding area
* Ability to travel to UNLV campus by self or possible caregiver for regular study visits
* Clinically significant symptoms of depression as evidenced by: 1) Scores \> 5 on the Geriatric Depression Scale-Short Form (GDS-SF)
* Mild cognitive impairment as evidenced by: 1) Scores \> 18 and \< 25 on the Montreal Cognitive Assessment (MoCA)

Exclusion Criteria

* Active suicidal ideation
* History of suicide attempt(s)
* Current symptoms of: 1) Psychosis; 2) Active substance use disorder
* Reported history of: 1) Bipolar disorder ("manic depression"); 2) Intellectual disability
* Currently in or scheduled to initiate individual psychotherapy to avoid treatment interference
* Psychotropic medication permitted if dose was stable over the past 2 weeks
* Currently living in an institutional setting (e.g., assisted living, inpatient, skilled nursing)
* Presence of notable memory-specific cognitive deficits as evidenced by: scores \< 9 on the MoCA memory subscale (rendering it difficult to participate in and track/recall events for weekly psychotherapy)

Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No